AbbVie Inc. (ABBV) vs NVIDIA Corporation (NVDA)
NVDA leads on 11 of 15 compared metrics.
A side-by-side comparison of AbbVie Inc. and NVIDIA Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 15, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — ABBV vs NVDA
growth of $100 · last 14yABBV +550.7%NVDA +68553.0%NVDA compounded faster
Log scale — wide-divergence pair
ABBV NVDA
ABBV vs NVDA: by the numbers
- •NVDA is the larger company ($4.97T vs $402.35B market cap).
- •NVDA trades at the lower earnings multiple (31.42 vs 111.67 P/E).
- •NVDA converts more revenue to profit (62.97% vs 5.79% net margin).
- •NVDA grew revenue faster over the past five years (68.23% vs 4.59% CAGR).
- •ABBV pays the higher dividend yield (2.96% vs 0.01%).
Which is better, ABBV or NVDA?
Metric tally: ABBV 4 · NVDA 11It depends on what you're optimizing for:
ValueNVDA(lower P/E)
GrowthNVDA(faster 5Y revenue CAGR)
IncomeABBV(higher dividend yield)
QualityNVDA(higher ROIC)
Metrics side by side
Valuation
| Metric | ABBV | NVDA |
|---|---|---|
| P/E ratio | 111.67 | 31.42● |
| Forward P/E | — | 16.44 |
| P/S ratio | 6.43● | 19.74 |
| P/B ratio | 14.69● | 25.60 |
| PEG ratio | — | 0.57 |
| EV / EBITDA | 27.63 | 25.96● |
| FCF yield | 5.17%● | 2.38% |
Profitability
| Metric | ABBV | NVDA |
|---|---|---|
| Gross margin | 70.68% | 74.15%● |
| Operating margin | 27.60% | 64.02%● |
| Net margin | 5.79% | 62.97%● |
| ROE | 13.23% | 81.65%● |
| ROIC | 12.97% | 62.88%● |
Dividends
| Metric | ABBV | NVDA |
|---|---|---|
| Dividend yield | 2.96%● | 0.01% |
| Payout ratio | 284.39% | 0.61% |
Growth (annualized)
| Metric | ABBV | NVDA |
|---|---|---|
| Revenue CAGR (5Y) | 4.59% | 68.23%● |
| EPS CAGR (5Y) | -2.79% | 85.78%● |
| FCF CAGR (5Y) | 3.24% | 85.52%● |
| Total return CAGR (5Y) | 18.95% | 63.05%● |
Frequently asked
- Which is better, ABBV or NVDA?
- It depends on your goal. value: NVDA (lower P/E); growth: NVDA (faster 5Y revenue CAGR); income: ABBV (higher dividend yield); quality: NVDA (higher ROIC). Across all compared metrics, NVDA leads 11 to 4.
- Is ABBV or NVDA cheaper?
- On trailing earnings, NVDA is cheaper: ABBV trades at a 111.67 P/E and NVDA at 31.42.
- Which has grown faster, ABBV or NVDA?
- Over the past five years, NVDA grew revenue faster — ABBV at a 4.59% CAGR versus NVDA at 68.23%.
- Does ABBV or NVDA pay a bigger dividend?
- ABBV yields 2.96% and NVDA yields 0.01% based on trailing dividends and the latest price.
- Is ABBV or NVDA more profitable?
- NVDA runs the higher net margin — ABBV at 5.79% versus NVDA at 62.97%.
- Which has been the better investment, ABBV or NVDA?
- Over the past 10-year, NVDA delivered the higher annualized total return — ABBV at 18.88% versus NVDA at 68.06%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AbbVie P/E ratioNVIDIA P/E ratioAbbVie dividend yieldNVIDIA dividend yieldAbbVie ROENVIDIA ROEAbbVie operating marginNVIDIA operating marginAbbVie revenue growthNVIDIA revenue growthAbbVie free cash flowNVIDIA free cash flow
AbbVie & NVIDIA appear in these rankings
Related comparisons
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 15, 2026.